Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 3
Encontrada(s) 1 página(s)

Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Crosstalk between intestinal serotonergic system and pattern recognition receptors on microbiota-gut-brain axis

  • Layunta, Elena
  • Buey, Berta
  • Mesonero, Jose Emilio
  • Latorre, Eva
Disruption of the microbiota–gut–brain axis results in a wide range of pathologies that are affected, from the brain to the intestine. Gut hormones released by enteroendocrine cells to the gastrointestinal (GI) tract are important signaling molecules within this axis. In the search for the language that allows microbiota to communicate with the gut and the brain, serotonin seems to be the most important mediator. In recent years, serotonin has emerged as a key neurotransmitter in the gut–brain axis because it largely contributes to both GI and brain physiology. In addition, intestinal microbiota are crucial in serotonin signaling, which gives more relevance to the role of the serotonin as an important mediator in microbiota–host interactions. Despite the numerous investigations focused on the gut–brain axis and the pathologies associated, little is known regarding how serotonin can mediate in the microbiota–gut–brain axis. In this review, we will mainly discuss serotonergic system modulation by microbiota as a pathway of communication between intestinal microbes and the body on the microbiota–gut–brain axis, and we explore novel therapeutic approaches for GI diseases and mental disorders.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Neurotransmitter Dysfunction in Irritable Bowel Syndrome: Emerging Approaches for Management

  • Gros, Mónica
  • Gros, Belén
  • Mesonero, José Emilio
  • Latorre, Eva
Irritable bowel syndrome (IBS) is a functional gastrointestinal disorder whose aetiology is still unknown. Most hypotheses point out the gut-brain axis as a key factor for IBS. The axis is composed of different anatomic and functional structures intercommunicated through neurotransmitters. However, the implications of key neurotransmitters such as norepinephrine, serotonin, glutamate, GABA or acetylcholine in IBS are poorly studied. The aim of this review is to evaluate the current evidence about neurotransmitter dysfunction in IBS and explore the potential therapeutic approaches. IBS patients with altered colorectal motility show augmented norepinephrine and acetylcholine levels in plasma and an increased sensitivity of central serotonin receptors. A decrease of colonic mucosal serotonin transporter and a downregulation of α2 adrenoceptors are also correlated with visceral hypersensitivity and an increase of 5-hydroxyindole acetic acid levels, enhanced expression of high affinity choline transporter and lower levels of GABA. Given these neurotransmitter dysfunctions, novel pharmacological approaches such as 5-HT3 receptor antagonists and 5-HT4 receptor agonists are being explored for IBS management, for their antiemetic and prokinetic effects. GABA-analogous medications are being considered to reduce visceral pain. Moreover, agonists and antagonists of muscarinic receptors are under clinical trials. Targeting neurotransmitter dysfunction could provide promising new approaches for IBS management.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Dietary intake as a tool to support diagnosis of irritable bowel syndrome

  • Gros, Mónica
  • Gros-Bañeres, Belén
  • Mesonero, José Emilio
  • Latorre, Eva
Background Dietary habits are closely related to symptom modulation in irritable bowel syndrome (IBS), yet their characterization remains limited. Understanding habitual food intake in IBS patients may contribute to diagnosis and support personalized management. Objectives To identify dietary patterns associated with IBS and to develop a diet-based score to aid in clinical stratification and nutritional guidance. Methods A case–control study was conducted including 109 participants (53 IBS patients and 56 healthy controls). Dietary intake was assessed using a validated short food frequency questionnaire. Multivariate logistic regression identified food items that best distinguished IBS patients from controls, which were then used to construct a composite dietary score. Results IBS patients exhibited distinct dietary patterns, characterized by higher intake of carbohydrates and lower consumption of dairy products, while fruit and vegetable intake were similar between groups. A score based on the intake of rice, bread, yoghurt, minced meat, and distilled beverages showed good discriminatory capacity (sensitivity: 85.7%, specificity: 81.1%). Conclusions IBS patients present characteristic dietary profiles that may have diagnostic and therapeutic implications. The proposed dietary score could serve as a complementary tool to support clinical decision-making and guide personalized nutritional counseling. Further research is warranted to validate its applicability in routine clinical practice.